The efficiency of the serum prostate specific antigen levels in diagnosing prostatic enlargements
- PMID: 23450716
- PMCID: PMC3576757
- DOI: 10.7860/JCDR/2012/4926.2676
The efficiency of the serum prostate specific antigen levels in diagnosing prostatic enlargements
Abstract
Background: The objective of this study was to evaluate the serum PSA levels in patients presenting with enlarged prostate and to evaluate the efficiency of serum PSA to diagnose and differentiate benign and malignant enlargements.
Methods: The authors evaluated the patients coming in surgical OPD with enlarged prostate and were advised to undergo serum PSA testing.
Results: The efficiency of serum PSA to differentiate Benign and malignant lesions was 97.18% and 83.33% respectively.
Keywords: Prostate Specific Antigen.
References
-
- Mandhani A. Early prostate cancer: Radical prostatectomy or watchful waiting. The Nat Med Journ of India. 2005 Jul/Aug;18(4) - PubMed
-
- Yeole BB. Trends in Prostate cancer incidence in India. Asian Pacific J Cancer Prev. 9:141–44. - PubMed
-
- Placer J, Morote J. Usefulness of prostatic specific antigen (PSA) for diagnosis and staging of patients with prostate cancer. Arch Espl Urol. 2011 Oct;(8):659–80. - PubMed
-
- Chen CH, Yao HH, Huang SW, Chuang CK, Hsu HS, Wang CJ, Pu YS. Using age-referenced prostate-specific antigen percentile to predict survival outcomes in screened taiwanese men. Int J Cancer. 2012 Sep 14 doi: 10.1002/ijc.27842. [Epub ahead of print] - PubMed
-
- Joseph E, Osterling MD, Michael M. Serum PSA in a communitybased population of healthy men. Establishment of Age-Specific Reference Ranges. JAMA. 1993 Aug 18;270:860–64. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous